Segment Reporting (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2024 USD ($) item	Dec. 31, 2023 USD ($)
Segment Reporting Information [Line Items]
Number of Reportable Segments | item	1
Segment Reporting Information, Profit (Loss) [Abstract]
Total Revenue	$ 38,627	$ 41,288
Cost of goods sold	7,100	4,742
Gross profit	31,527	36,546
Research and development	22,227	23,817
Sales and marketing	26,661	26,975
General and administrative	29,693	30,068
Depreciation and amortization	4,143	3,985
Stock-based compensation expense	13,083	13,979
Total operating expenses	82,724	84,845
Other income/expense	10,142	10,376
Net loss	(41,055)	(37,923)
Cell Engineering Technology Segment
Segment Reporting Information, Profit (Loss) [Abstract]
Core Revenue	32,512	29,823
Non-core Revenue	6,115	11,465
Total Revenue	38,627	41,288
Cost of goods sold	7,100	4,742
Gross profit	31,527	36,546
Research and development	19,264	19,204
Sales and marketing	23,741	23,723
General and administrative	22,493	23,954
Depreciation and amortization	4,143	3,985
Stock-based compensation expense	13,083	13,979
Total operating expenses	82,724	84,845
Other income/expense	10,142	10,376
Net loss	$ (41,055)	$ (37,923)